170033-53-1 Usage
Uses
Used in Pharmaceutical Industry:
(R)-<2-<(2-Hydroxyethyl)(phenylmethyl)amino>-1-methyl-2-oxoethyl>carbamic acid 1,1-dimethylethyl ester is used as a potential pharmaceutical compound for its diverse functional groups that may contribute to its activity against certain diseases or conditions. The presence of the carbamic acid ester and phenylmethyl amino group could be particularly relevant for drug design, as these moieties are commonly found in biologically active molecules.
Used in Chemical Synthesis:
In the chemical synthesis industry, (R)-<2-<(2-Hydroxyethyl)(phenylmethyl)amino>-1-methyl-2-oxoethyl>carbamic acid 1,1-dimethylethyl ester may serve as a building block or intermediate in the synthesis of more complex molecules. Its unique structure, including the hydroxyethyl and oxoethyl groups, could be exploited to create novel compounds with specific properties or reactivity.
Used in Material Science:
(R)-<2-<(2-Hydroxyethyl)(phenylmethyl)amino>-1-methyl-2-oxoethyl>carbamic acid 1,1-dimethylethyl ester's structural features may also find applications in material science, where it could be used to develop new materials with tailored properties. The phenylmethyl amino group, in particular, could influence the compound's interaction with other molecules, potentially leading to materials with unique mechanical, electronic, or optical characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 170033-53-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,0,3 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 170033-53:
(8*1)+(7*7)+(6*0)+(5*0)+(4*3)+(3*3)+(2*5)+(1*3)=91
91 % 10 = 1
So 170033-53-1 is a valid CAS Registry Number.
170033-53-1Relevant academic research and scientific papers
Use of imidazo?1,5-a!quinolones as neuroprotective agents
-
, (2008/06/13)
The imidazo?1,5-a!quinolines (I) are useful in treating neurological diseases/conditions or chronic neurodegenerative diseases/conditions.
Asymmetric Synthesis of 2,6-Methylated Piperazines
Mickelson, John W.,Belonga, Kenneth L.,Jacobsen, Jon E.
, p. 4177 - 4183 (2007/10/02)
The complete series of enantiopure 2,6-methylated piperazines was synthesized utilizing two alternative reactions in the key bond-forming step.The dimethyl enantiomers, (2R,6R)- and (2S,6S)-2,6-dimethylpiperazine (1, 2), were prepared using either a diastereoselective triflate alkylation or a novel intermolecular Mitsunobu reaction to set the required stereochemistry.The monomethyl derivatives, (R)- and (S)-tert-butyl 2-methyl-1-piperazinecarboxylate (3, 4) were also synthesized employing the Mitsunobu cyclization strategy while the trimethyl compounds, (R)- and (S)-2,2,6- trimethylpiperazine (5, 6) were prepared using an enantiospecific triflate alkylation as the principal reaction.These methods represent efficient, general strategies for preparing a variety of 2,6-methylated piperazines for which the absolute stereochemistry can be readily controlled.
